• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    UPDATE - International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15, 2025

    5/8/25 10:44:07 AM ET
    $BLTE
    $COE
    $HCM
    $IH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Other Consumer Services
    Real Estate
    Get the next $BLTE alert in real time by email

    NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Thursday, May 15, 2025 featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the United States.

    Representatives from participating companies based in China, Hong Kong, Philippines, Denmark, Germany, South Africa, Switzerland, Sweden, and the United Kingdom will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies.

    There is no fee for participants to log in, attend live presentations and/or ask questions.

    Pre-registration is suggested. Please register here: www.adr.db.com/dbvic

    Conference Agenda May 15th, 2025 (US Eastern Standard Time):

    • 8:00 AM: Bavarian Nordic A/S ((Nasdaq Copenhagen: BAVA, OTC:BVNRY)  
    • 8:30 AM: Viomi Technology Co., Ltd (NASDAQ:VIOT)
    • 9:00 AM: Infineon Technologies AG ((Xetra: IFX, OTC:IFNNY)
    • 9:30 AM: Clicks Group Ltd ((JSE: CLS, OTC:CLCGY)
    • 10:00 AM: First Pacific Company Ltd ((HKEX: 142, OTC:FPAFY)
    • 10:30 AM: HUTCHMED (China) Limited (AIM: HCM, NASDAQ:HCM, and HKEX:13)
    • 11:00 AM: 51Talk Online Education Group (NYSE:COE)
    • 11:30 AM: Yiren Digital Ltd. (NYSE:YRD)
    • 12:00 PM: ABB Ltd. ((SIX: ABBN, OTC:ABBNY)
    • 12:30 PM: Belite Bio, Inc  (NASDAQ:BLTE)
    • 13:00 PM: Epiroc AB ((Nasdaq Stockholm: EPIA, OTC:EPOAY)
    • 13:30 PM: International Airlines Group ((LSE: IAG, MAD: IAG, OTC:ICAGY)
    • 14:00 PM: BDO Unibank, Inc ((PSE: BDO, OTC:BDOUY)
    • 14:30 PM: iHuman Inc. (NYSE:IH)

    The presentations will be available for replay after the conference.

    In addition to specializing in administering cross-border equity structures such as American and Global Depositary Receipts, Deutsche Bank provides corporates, financial institutions, hedge funds and supranational agencies around the world with trustee, agency, escrow and related services. The Bank offers a broad range of services for diverse products, from complex securitizations and project finance to syndicated loans, debt exchanges and restructurings.

    For further information, please contact:

    Dylan Riddle

    Deutsche Bank AG

    Press & Media Relations

    Tel. +12122504982

    Cell. +1(904)3866481

    Email [email protected]

    Deutsche Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany's leading bank, with a strong position in Europe and a significant presence in the Americas and Asia Pacific.

    Deutsche Bank is sponsoring the Deutsche Bank Depositary Receipt Investor Conference solely for informational purposes. Deutsche Bank does not prepare, review, approve or edit any presentations, statements, documents or other information or materials, whether in written, electronic or verbal form, provided by any company participating in such conference, and disclaims any responsibility for the accuracy or adequacy of any such information or materials. Deutsche Bank is not promoting, endorsing or recommending any company participating in the conference.

    The Depositary Receipts have been registered pursuant to the US Securities Act of 1933 (the "Act") on Form F-6. The investment or investment service which is the subject of this notice is not available to retail clients as defined by the UK Financial Conduct Authority. This notice has been approved and/or communicated by Deutsche Bank AG New York. The services described in this notice are provided by Deutsche Bank Trust Company Americas (Deutsche Bank) or by its subsidiaries and/or affiliates in accordance with appropriate local registration and regulation. Deutsche Bank is providing the attached notice strictly for information purposes and makes no claims or statement, nor does it warrant as to or guarantee the accuracy or completeness of the details contained herein and does not undertake an obligation to update or amend this information. Deutsche Bank, its subsidiaries and/or affiliates disclaims any and all liability to fullest extent permitted by law, whether arising in tort, contract or otherwise, which any of them might otherwise have in respect of the above information. This announcement appears as a matter of record only. Neither this announcement nor the information contained herein constitutes an offer or solicitation by Deutsche Bank or any other issuer or entity for the purchase or sale of any securities in the United States, nor does it constitute an offer or solicitation to any person in any other jurisdiction. No part of this notice may be copied or reproduced in any way without the prior written consent of Deutsche Bank. Past results are not an indication of future performance. Copyright© May 2025 Deutsche Bank AG. All rights reserved.



    Primary Logo

    Get the next $BLTE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BLTE
    $COE
    $HCM
    $IH

    CompanyDatePrice TargetRatingAnalyst
    HUTCHMED (China) Limited
    $HCM
    5/13/2025Buy → Hold
    HSBC Securities
    Belite Bio Inc
    $BLTE
    12/14/2023$60.00Buy
    Maxim Group
    HUTCHMED (China) Limited
    $HCM
    11/24/2023Hold → Buy
    Deutsche Bank
    Belite Bio Inc
    $BLTE
    7/28/2023$43.00Overweight
    Cantor Fitzgerald
    Belite Bio Inc
    $BLTE
    7/26/2023$25.00Outperform
    SVB Securities
    iHuman Inc.
    $IH
    12/30/2022$3.10Buy
    Citigroup
    Belite Bio Inc
    $BLTE
    8/1/2022$58.00Buy
    H.C. Wainwright
    HUTCHMED (China) Limited
    $HCM
    5/4/2022Buy → Hold
    Deutsche Bank
    More analyst ratings

    $BLTE
    $COE
    $HCM
    $IH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    HUTCHMED downgraded by HSBC Securities

    HSBC Securities downgraded HUTCHMED from Buy to Hold

    5/13/25 3:20:36 PM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Maxim Group initiated coverage on Belite Bio with a new price target

    Maxim Group initiated coverage of Belite Bio with a rating of Buy and set a new price target of $60.00

    12/14/23 8:06:18 AM ET
    $BLTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HUTCHMED upgraded by Deutsche Bank

    Deutsche Bank upgraded HUTCHMED from Hold to Buy

    11/24/23 7:13:23 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BLTE
    $COE
    $HCM
    $IH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Belite Bio to Participate in Three Upcoming Investor Conferences

    SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the executive management team will participate in three upcoming investor conferences. Details of the presentations are as follows: Cantor Global Healthcare Conference September 5, 2025, at 8:00 am ET, fireside chat Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025, at 5:35 pm ET, fireside chat H.C. Wainwright 27th Annual Global Investment Conference September 9, 202

    8/27/25 8:00:00 AM ET
    $BLTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HUTCHMED Announces Appointment of Acting Chief Executive Officer

    HONG KONG and SHANGHAI and FLORHAM PARK, N.J, Aug. 25, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:​HCM; HKEX:​13) today announces that Dr Weiguo Su, an Executive Director of the Company, will take a leave of absence from his duties as Chief Executive Officer due to health reasons. In light of this, the Board of Directors has appointed Mr Johnny Cheng, an Executive Director and Chief Financial Officer of the Company, as Acting Chief Executive Officer with immediate effect, in addition to his role as Chief Financial Officer. Dr Dan Eldar, Chairman and Non-executive Director, said, "The Board expresses its full support for Dr Su and wishes him a speedy recover

    8/24/25 8:20:00 PM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Yiren Digital Reports Second Quarter 2025 Financial Results

    BEIJING, Aug. 21, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE:YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial services in Asia, today announced its unaudited financial results for the quarter ended June 30, 2025. Second Quarter 2025 Operational Highlights Financial Services Business Total loans facilitated in the second quarter of 2025 reached RMB20.3 billion (US$2.8 billion), representing an increase of 34% from RMB15.2 billion in the first quarter of 2025 and increase of 57% compared to RMB12.9 billion in the same period of 2024.Cumulative number of borrowers served reached 13,536,838 as of June 30, 2025, representing an incr

    8/21/25 6:37:00 AM ET
    $YRD
    Finance: Consumer Services
    Finance

    $BLTE
    $COE
    $HCM
    $IH
    SEC Filings

    View All

    SEC Form 6-K filed by HUTCHMED (China) Limited

    6-K - HUTCHMED (China) Ltd (0001648257) (Filer)

    8/25/25 6:15:40 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Yiren Digital Ltd.

    6-K - Yiren Digital Ltd. (0001631761) (Filer)

    8/22/25 6:02:49 AM ET
    $YRD
    Finance: Consumer Services
    Finance

    SEC Form 6-K filed by HUTCHMED (China) Limited

    6-K - HUTCHMED (China) Ltd (0001648257) (Filer)

    8/20/25 6:12:04 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BLTE
    $COE
    $HCM
    $IH
    Leadership Updates

    Live Leadership Updates

    View All

    HUTCHMED Announces Appointment of Acting Chief Executive Officer

    HONG KONG and SHANGHAI and FLORHAM PARK, N.J, Aug. 25, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:​HCM; HKEX:​13) today announces that Dr Weiguo Su, an Executive Director of the Company, will take a leave of absence from his duties as Chief Executive Officer due to health reasons. In light of this, the Board of Directors has appointed Mr Johnny Cheng, an Executive Director and Chief Financial Officer of the Company, as Acting Chief Executive Officer with immediate effect, in addition to his role as Chief Financial Officer. Dr Dan Eldar, Chairman and Non-executive Director, said, "The Board expresses its full support for Dr Su and wishes him a speedy recover

    8/24/25 8:20:00 PM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    51Talk Online Education Group to Present on the Emerging Growth Conference on June 17, 2025.

    51Talk Online Education Group invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference. SINGAPORE, June 12, 2025 /PRNewswire/ -- 51Talk Online Education Group (the "Company") (NYSE:COE), a global online education platform with core expertise in English education, is pleased to announce that it has been invited to present on the Emerging Growth Conference on June 17, 2025. The next Emerging Growth Conference is presenting on June 17, 2025. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's inve

    6/12/25 5:30:00 AM ET
    $COE
    Other Consumer Services
    Real Estate

    HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee

    HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED" or the "Company") (Nasdaq/AIM:​HCM, HKEX:​13) today announces that Mr Wong Tak Wai (Mr Alvin Wong) is appointed as an Independent Non-executive Director and a member of the Audit Committee of the Company with effect from March 6, 2025. Mr Wong has over 35 years of extensive experience in accounting, auditing and corporate finance. He has acted in a pivotal role in assisting companies with their stock exchange listings and has been instrumental in completing numerous mergers and acquisitions. After a distinguished career spanning more than three decades, Mr Wong retired as

    3/5/25 5:00:00 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BLTE
    $COE
    $HCM
    $IH
    Financials

    Live finance-specific insights

    View All

    Yiren Digital Reports Second Quarter 2025 Financial Results

    BEIJING, Aug. 21, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE:YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial services in Asia, today announced its unaudited financial results for the quarter ended June 30, 2025. Second Quarter 2025 Operational Highlights Financial Services Business Total loans facilitated in the second quarter of 2025 reached RMB20.3 billion (US$2.8 billion), representing an increase of 34% from RMB15.2 billion in the first quarter of 2025 and increase of 57% compared to RMB12.9 billion in the same period of 2024.Cumulative number of borrowers served reached 13,536,838 as of June 30, 2025, representing an incr

    8/21/25 6:37:00 AM ET
    $YRD
    Finance: Consumer Services
    Finance

    Yiren Digital to Report Second Quarter 2025 Financial Results on August 21, 2025

    BEIJING, Aug. 14, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE:YRD) ("Yiren Digital"), an AI-powered platform providing a comprehensive suite of financial services in Asia, announced that it plans to release its unaudited financial results for the second quarter ended June 30, 2025 before U.S. market opens on Thursday, August 21, 2025. Yiren Digital's management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on August 21, 2025 (or 8:00 p.m. Beijing/Hong Kong Time on August 21, 2025). Participants who wish to join the call should register online in advance of the conference at: https://dpregister.com/sreg/10202094/ffb82a2282 Once registration is completed, participants

    8/14/25 6:15:00 AM ET
    $YRD
    Finance: Consumer Services
    Finance

    Viomi Technology Co., Ltd Announces Declaration of a Special Dividend

    GUANGZHOU, China, July 14, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ:VIOT), a leading technology company for home water solutions in China, today announced that its board of directors has approved the declaration and distribution of a special dividend (the "Special Dividend") of US$0.0293 per ordinary share (US$0.0880 per American depositary share, or ADS). The aggregate amount of the Special Dividend will be approximately US$6 million. The Special Dividend is expected to be paid on or around August 18, 2025 to the holders of the Company's ordinary shares, and on or around August 21, 2025 to the holders of the Company's ADSs, of record, as of the

    7/14/25 7:45:42 AM ET
    $VIOT
    Consumer Electronics/Appliances
    Consumer Discretionary

    $BLTE
    $COE
    $HCM
    $IH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by 51Talk Online Education Group

    SC 13D/A - 51Talk Online Education Group (0001659494) (Subject)

    12/17/24 4:07:04 PM ET
    $COE
    Other Consumer Services
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Viomi Technology Co. Ltd

    SC 13G/A - Viomi Technology Co., Ltd (0001742770) (Subject)

    11/12/24 6:35:53 AM ET
    $VIOT
    Consumer Electronics/Appliances
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by 51Talk Online Education Group

    SC 13D/A - 51Talk Online Education Group (0001659494) (Subject)

    10/10/24 6:45:35 AM ET
    $COE
    Other Consumer Services
    Real Estate